STAT

How a wildlife biologist became a plague-chaser in the American Southwest

In Flagstaff, Ariz., when officials suspect an outbreak of plague — the disease that once wiped out about a third of Europe — David Wagner takes their call.

FLAGSTAFF, Ariz. — When there’s a suspected outbreak of plague in this college town among the pines, the authorities know to call David Wagner. He’s a tall man, with the square-jawed looks of the sheriff in a spaghetti Western, and one of his jobs is to determine whether these flare-ups are indeed caused by the same bacteria as the Black Death. He pulls on long pants and long sleeves — preferably white, so it’s easier to spot the dark speck of a flea — and drives out to the scene.

Usually, the corpses are already underground, not because they’ve been buried, but because they are prairie dogs. In the throes of plague, they crawl down into their burrows to die at home. Wagner isn’t there for their bodies. He’s more interested in the fleas that transmitted plague in the first place. Sometimes, like their dead hosts, they too are beneath the earth, and he needs to coax them out. At other times — when he’s investigating what he’d call a “hot site” —  the blood is gone from the corpses, the fleas have begun to starve, and they’ve jumped their way to the surface to wait for another mammal to pass by. “You can just see them popping around looking for something to feed on,” Wagner said. “It’s pretty creepy.”

The creepiness stems in part from the fact that a bite, , could give Wagner lumps the size of chicken eggs; make him bleed from his mouth, nose, and rectum; turn his extremities a gangrenous black; and kill him within days. The prospect doesn’t worry him much. He carries prophylactic antibiotics, which he’ll take if he starts to feel his muscles aching or his throat getting sore. He wears latex gloves. And really, more than a liability, his access to fleas full of

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT1 min read
STAT+: In Large Trial, Guardant Health’s Blood Test Detects Colon Cancer, But Less Reliably At Earliest Or Precancerous Stages
If approved, Guardant Health’s liquid biopsy is likely to be a strong new addition to colorectal cancer screening tools, particularly for patients who currently choose not to get screened.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks